Valuation: TransMedics Group, Inc.

Market Cap 2.46B 2.15B 1.98B 1.84B 3.49B 233B 3.54B 23.77B 9.24B 115B 9.23B 9.03B 398B P/E 2026 *
37.3x
P/E 2027 * 21.7x
Enterprise Value 2.49B 2.18B 2.01B 1.86B 3.54B 236B 3.59B 24.1B 9.37B 117B 9.35B 9.15B 403B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 2.79x
Free-Float
96.57%
Yield 2026 *
-
Yield 2027 * -
1 day-1.31%
1 week+3.50%
Current month+5.73%
1 month-1.29%
3 months-35.79%
6 months-48.95%
Current year-42.27%
1 week 67.87
Extreme 67.87
73
1 month 64.84
Extreme 64.8448
80.72
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 1998-07-31
Director of Finance/CFO 55 2024-12-01
Chief Operating Officer 43 2023-02-01
Director TitleAgeSince
Director/Board Member 57 1998-07-31
Chairman 81 2010-12-31
Director/Board Member 78 2016-01-31
Date Insider Type Main position Quantity % Market Cap.
06-14Fiscal year

Director

48,194 0.1414%
05-19Free

Director

2,922 0.0086%
05-19Free

Director

2,922 0.0086%
Change 5-day change 1-year change 3-year change Capi.($)
-1.31%+3.50%-43.70%-18.77% 2.46B
-1.23%-0.86%+19.41%-1.54% 192B
-2.12%+4.01%-20.63%+22.99% 151B
-1.58%-1.32%-4.74%-18.47% 137B
-1.29%+3.95%-56.29%-15.07% 67.33B
-0.88%+2.02%+22.86%+2.41% 54.6B
-2.14%+0.26%-26.31%-30.46% 44.94B
-1.11%-2.11%+6.43%+39.85% 36.81B
-1.98%-3.59%+6.27%+8.65% 37.04B
-5.04%+3.98%-18.51%-3.47% 31.7B
Average -1.85%+4.65%-11.52%-1.39% 75.56B
Weighted average by Cap. -1.69%+4.09%-5.29%+0.03%

Financials

2026 *2027 *
Net sales 734M 642M 592M 548M 1.04B 69.62B 1.06B 7.09B 2.76B 34.36B 2.75B 2.69B 119B 869M 760M 700M 649M 1.23B 82.44B 1.25B 8.4B 3.27B 40.68B 3.26B 3.19B 141B
Net income 75.93M 66.45M 61.24M 56.76M 108M 7.21B 109M 734M 286M 3.56B 285M 279M 12.29B 132M 115M 106M 98.43M 187M 12.5B 190M 1.27B 495M 6.17B 494M 484M 21.32B
Net Debt 33.99M 29.75M 27.41M 25.41M 48.24M 3.23B 49.01M 329M 128M 1.59B 128M 125M 5.5B -30.91M -27.05M -24.93M -23.1M -43.86M -2.93B -44.56M -299M -116M -1.45B -116M -114M -5B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
26-07-08 US$70.25 -1.22% 98,312
26-07-07 US$71.12 -0.16% 754,297
26-07-06 US$71.23 +3.44% 946,322
26-07-02 US$68.86 +1.49% 832,769
26-07-01 US$67.85 +2.15% 1,058,677
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
71.12USD
Average target price
116.22USD
Spread / Average Target
+63.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock